Preferred Name |
Ipilimumab |
|
Synonyms |
MDX010 |
|
Definitions |
An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells. |
|
ID |
http://purl.bioontology.org/ontology/MESH/D000074324 |
|
altLabel |
MDX010 Anti CTLA 4 MAb Ipilimumab Yervoy MDX 010 Anti-CTLA-4 MAb Ipilimumab MDX CTLA 4 Ipilimumab, Anti-CTLA-4 MAb MDX-010 MDX-CTLA-4 |
|
AQL |
AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR |
|
cui |
C1692339 C1691227 C3154308 C1367202 |
|
DC |
1 |
|
definition |
An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells. |
|
DX |
20180101 |
|
FX |
D060908 |
|
HN |
2018(2012) |
|
Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000096 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000648 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000502 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000187 http://purl.bioontology.org/ontology/MESH/Q000235 http://purl.bioontology.org/ontology/MESH/Q000633 |
|
Inverse of RB |
0 |
|
Inverse of RO | ||
isa | ||
LT |
TRD |
|
Machine permutation |
2018; IPILIMUMAB was indexed under ANTIBODIES, MONOCLONAL, 2012-2017 |
|
MDA |
20170711 |
|
MMR |
20200228 |
|
MN |
D12.776.124.790.651.114.224.060.798 D12.776.124.486.485.114.224.060.798 D12.776.377.715.548.114.224.200.798 |
|
notation |
D000074324 |
|
PA |
D000074322 D000082082 |
|
prefLabel |
Ipilimumab |
|
RR |
6T8C155666 |
|
TERMUI |
T668085 T668091 T000915139 T668086 T791808 T000915128 T668087 |
|
TH |
FDA SRS (2017) NLM (2006) NLM (2018) NLM (2011) |
|
tui |
T116 T129 T121 |
|
subClassOf |